TOKYO -- The Tokyo Metropolitan Government plans to conduct clinical trials of the anti-parasitic drug Ivermectin at metropolitan and public hospitals to assess its effectiveness against COVID-19, Nikkei has learned.
Coronavirus
Tokyo considers trials of parasite drug for COVID-19
Ivermectin tablets to be assessed for possible home use
The Tokyo Metropolitan Government plans to conduct clinical trials of the anti-parasitic drug Ivermectin to assess its effectiveness in treating COVID-19 patients with mild symptoms. © Reuters
Read Next
Latest on Coronavirus
